Allied Corp. (ALID)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Paul Bullock | COO, Interim CFO & Director | 92.63k | -- | -- |
| Mr. James Smeeding M.B.A., MBA, R.Ph., RPh | VP of Pharmaceuticals Development & Director | 60k | -- | 1950 |
| Mr. Michael Moses | Chief Business Development Officer | 150.03k | -- | -- |
| Dr. Radka Milanova Ph.D. | Chief Scientific Director | -- | -- | -- |
Allied Corp.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Allied Corp., a cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States. The company operates in two segments, Allied Colombia and Allied Corp. It offers hemp-based CBD natural health products, as well as cannabis related products, including beauty and skincare products, and foods and beverages. The company also develops ALID 10 and ALID 11 for the treatment of post-traumatic stress disorder and related mental health conditions through the targeted function of the 5-HT2 receptor and physiological pathways. Allied Corp. is headquartered in Kelowna, Canada
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
February 11, 2025 at 12:00 AM UTC
15-12G: Notice of termination of registration of a class of securities under Section 12(g)
February 3, 2025 at 12:00 AM UTC
25: Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange